Yüklüyor......
Interleukin-2 treatment of tumor patients can expand regulatory T cells
Augmented numbers of regulatory T cells contribute to the overall immunosuppression in tumor patients. Interleukin-2 has been widely used in the clinics in anticancer therapy, yet evidence has accumulated that the major drawback, limiting clinical efficacy, is the expansion of regulatory T cells, wh...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3494638/ https://ncbi.nlm.nih.gov/pubmed/23170272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20639 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|